[
    [
        {
            "time": "",
            "original_text": "疫苗4月批签发数据专题：疫苗行业系列报告之批签发跟踪",
            "features": {
                "keywords": [
                    "疫苗",
                    "批签发",
                    "行业",
                    "数据"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "疫苗4月批签发数据专题：疫苗行业系列报告之批签发跟踪",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "医药-2020年4月疫苗批签发数据跟踪：行业整体批签发量持续增长 上市公司核心产品维持高速增长",
            "features": {
                "keywords": [
                    "医药",
                    "疫苗",
                    "批签发",
                    "增长",
                    "上市公司"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药-2020年4月疫苗批签发数据跟踪：行业整体批签发量持续增长 上市公司核心产品维持高速增长",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "贵州茅台又火了 这些基金或成最大赢家",
            "features": {
                "keywords": [
                    "贵州茅台",
                    "基金",
                    "赢家"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "消费"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "贵州茅台又火了 这些基金或成最大赢家",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "监管部门表示关注 沃森生物\"佛系\"大股东刘俊辉3亿定增康泰生物很\"狼性\"",
            "features": {
                "keywords": [
                    "沃森生物",
                    "刘俊辉",
                    "定增",
                    "康泰生物"
                ],
                "sentiment_score": 0.5,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "监管部门表示关注 沃森生物\"佛系\"大股东刘俊辉3亿定增康泰生物很\"狼性\"",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "[民生医药|周报]分化行情下甄选高景气板块，推荐API及医药外包",
            "features": {
                "keywords": [
                    "民生医药",
                    "周报",
                    "分化",
                    "高景气",
                    "API",
                    "医药外包"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "[民生医药|周报]分化行情下甄选高景气板块，推荐API及医药外包",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "首次，茅台市值超越贵州GDP！A股版漂亮50回归？",
            "features": {
                "keywords": [
                    "茅台",
                    "市值",
                    "贵州GDP",
                    "A股",
                    "漂亮50"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "消费"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "首次，茅台市值超越贵州GDP！A股版漂亮50回归？",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 10,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "沃森生物大股东被动上位1个月就拟减持 转头认购同行股票 控制人变化",
            "features": {
                "keywords": [
                    "沃森生物",
                    "大股东",
                    "减持",
                    "同行股票",
                    "控制人变化"
                ],
                "sentiment_score": 0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "沃森生物大股东被动上位1个月就拟减持 转头认购同行股票 控制人变化",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "沃森生物大股东怎么了？被动上位1个月就减持 转头认购同行股票 控制人变化",
            "features": {
                "keywords": [
                    "沃森生物",
                    "大股东",
                    "减持",
                    "同行股票",
                    "控制人变化"
                ],
                "sentiment_score": 0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "沃森生物大股东怎么了？被动上位1个月就减持 转头认购同行股票 控制人变化",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        }
    ]
]